Search | IOVS | ARVO Journals

Showing 1 – 20 of 93

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Low Vision September 2019

Binocular Inhibition of Reading in Macular Telangiectasia Type 2

PDF

Simone Tzaridis; Philipp Herrmann; Peter Charbel Issa; Simona Degli Esposti; Siegfried K Wagner; Marcus Fruttiger; Catherine Egan; Gary Rubin; Frank G. Holz; Tjebo F. C. Heeren
TAGS: eye, reading (activity), reading speed, scotoma, telangiectasis
Invest. Ophthalmol. Vis. Sci.. 2019; 60(12):3835-3841. doi: 10.1167/iovs.18-26414

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Reading with macular telangiectasia type 2 – a case of binocular confusion.

Tjebo Heeren; Simone Tzaridis; Catherine A Egan; Frank G. Holz; Peter Charbel Issa; Simona Degli Esposti; Philipp Herrmann; Siegfried Karl Wagner; Marcus Fruttiger; Gary S Rubin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4997. doi:

ARVO Annual Meeting Abstract July 2019

Fundus autofluorescence in macular telangiectasia type 2

Peter Charbel Issa; Laurenz Pauleikhoff; Tjebo Heeren; Konstantinos Balaskas; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5001. doi:

ARVO Annual Meeting Abstract July 2019

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Ferenc B Sallo; Vincent Rocco; Irene Leung; Adam M Dubis; Ute EK Wolf-Schnurrbusch; Catherine A Egan; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5049. doi:

ARVO Annual Meeting Abstract July 2019

Seasonal variation of first presentation with neovascular age-related macular degeneration

Roy Schwartz; Tjebo Heeren; Adnan Tufail; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):62. doi:

ARVO Annual Meeting Abstract July 2019

Automated Machine Learning Pipeline for Predicting Retinal Sensitivity from Optical Coherence Tomography in Macular Telangiectasia Type 2

Yuka Kihara; Tjebo Heeren; yue wu; Ted Spaide; Sa Xiao; Catherine A Egan; Cecilia S Lee; Aaron Lee

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1450. doi:

ARVO Annual Meeting Abstract July 2019

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Emily Y Chew; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Ferenc B Sallo; Tjebo Heeren; Catherine A Egan; Peter Charbel Issa; Konstatinos Balaskas; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1335. doi:

Articles June 2019

High-Resolution In Vivo Fundus Angiography using a Nonadaptive Optics Imaging System

PDF

Mali Okada; Tjebo F. C. Heeren; Pádraig J. Mulholland; Peter M. Maloca; Marketa Cilkova; Vincent Rocco; Marcus Fruttiger; Catherine A. Egan; Roger S. Anderson; Adnan Tufail
TAGS: angiogram, diagnostic imaging, optics, mosaicism
Trans. Vis. Sci. Tech.. 2019; 8(3):54. doi: 10.1167/tvst.8.3.54

Includes: Multimedia, Supplemental Content

Retina April 2019

Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2

PDF

Tjebo F. C. Heeren; Simone Tzaridis; Roberto Bonelli; Maximilian Pfau; Marcus Fruttiger; Mali Okada; Catherine Egan; Peter Charbel Issa; Frank G. Holz
TAGS: color, perimetry, rod photoreceptors, telangiectasis, eye
Invest. Ophthalmol. Vis. Sci.. 2019; 60(5):1760-1767. doi: 10.1167/iovs.18-25360

ARVO Annual Meeting Abstract July 2018

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Daniela Florea; Tatiana Mansour; Traci Clemons; Konstantinos Balaskas; Catherine Egan; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1034. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal Assessment Of Reading Test Performance In Patients With Type 2 Macular Telangiectasia (MacTel)

Simona Degli Esposti; Sarah Sirrell; Tjebo FC Heeren; Catherine Egan; Gary S Rubin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1262. doi:

ARVO Annual Meeting Abstract July 2018

Twelve-month longitudinal study of remnant cone structure in macular telangiectasia type 2

Mali Okada; Katie M Litts; Tjebo FC Heeren; Angelos Kalitzeos; Vincent Rocco; Rebecca Mastey; Navjit Singh; Thomas Kane; Melissa Kasilian; Michel Michaelides; Marcus Fruttiger; Joseph Carroll; Catherine Egan

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4628. doi:

ARVO Annual Meeting Abstract July 2018

Macular photoreceptor atrophy defines the end stage of macular telangiectasia type 2

Tjebo FC Heeren; Traci E Clemons; Marcus Fruttiger; Catherine Egan; Peter Charbel Issa

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3138. doi:

ARVO Annual Meeting Abstract July 2018

Human Serum Metabolomics Study in Macular Telangiectasia Type 2

Sasha Woods; Michael Powner; Senthil Selvam; Kamron Khan; Robyn H Guymer; Jennifer Trombley; Catherine Egan; Martin Friedlander; Marcus Fruttiger

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3154. doi:

Articles July 2018

High-Performance Virtual Reality Volume Rendering of Original Optical Coherence Tomography Point-Cloud Data Enhanced With Real-Time Ray Casting

PDF

Peter M Maloca; J. Emanuel Ramos de Carvalho; Tjebo Heeren; Pascal W Hasler; Faisal Mushtaq; Mark Mon-Williams; Hendrik P.N. Scholl; Konstantinos Balaskas; Catherine Egan; Adnan Tufail; Lilian Witthauer; Philippe C. Cattin
TAGS: casts, surgical, software, diagnostic imaging, virtual reality, optical coherence tomography, volume rendering
Trans. Vis. Sci. Tech.. 2018; 7(4):2. doi: 10.1167/tvst.7.4.2

Includes: Multimedia, Supplemental Content

Articles July 2018

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring

PDF

Peter Maloca; Pascal W. Hasler; Daniel Barthelmes; Patrik Arnold; Mooser Matthias; Hendrik P. N. Scholl; Heinrich Gerding; Justus Garweg; Tjebo Heeren; Konstantinos Balaskas; J. Emanuel Ramos de Carvalho; Catherine Egan; Adnan Tufail; Sandrine A. Zweifel
TAGS: safety, eye, retina, optical coherence tomography
Trans. Vis. Sci. Tech.. 2018; 7(4):8. doi: 10.1167/tvst.7.4.8

ARVO Annual Meeting Abstract June 2017

Retinal Layer Location of Increased Retinal Thickness and Retinal Thinning on the cohort of the EUROCONDOR clinical trial

Miguel Ângelo Costa; Luísa Ribeiro; Jose Garcia-Arumi; Peter Scanlon; Jakob Grauslund; Francesco Bandello; Jonathan Gibson; Edoardo Midena; Gabriele Elisabeth Lang; Simon P Harding; Catherine A Egan; Pascale Massin; Torcato Santos; Berta Ponsati; Jose G Cunha-Vaz; Rafael Simó

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):62. doi:

ARVO Annual Meeting Abstract June 2017

Imaging of remnant cone structure in outer retinal lesions in macular telangiectasia (MacTel) type 2

Katie M Litts; Mali Okada; Angelos Kalitzeos; Melissa Kasilian; Rebecca Mastey; Michel Michaelides; Joseph Carroll; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):6007. doi:

ARVO Annual Meeting Abstract June 2017

Clinical Features Predict Diabetic Retinopathy Progression

Cecilia S Lee; Aaron Y Lee; Doug Baughman; Atul Varma; Salim Natha; Louise Downey; Geeta Menon; Sajjad Mahmood; Usha Chakravarthy; David Paul Crabb; Alastair K Denniston; Clare Bailey; Adnan Tufail; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4283. doi:

ARVO Annual Meeting Abstract June 2017

Changes in glycated hemoglobin levels following consultation with diabetes specialist nurse in retinal clinics

Mahmood El-Gasim; Razia Amin; Shehab Al-Abed; adam mapani; Omar Abdul Rahman Mahroo; Declan Flanagan; Catherine A Egan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2897. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Binocular Inhibition of Reading in Macular Telangiectasia Type 2

Reading with macular telangiectasia type 2 – a case of binocular confusion.

Fundus autofluorescence in macular telangiectasia type 2

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Seasonal variation of first presentation with neovascular age-related macular degeneration

Automated Machine Learning Pipeline for Predicting Retinal Sensitivity from Optical Coherence Tomography in Macular Telangiectasia Type 2

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

High-Resolution In Vivo Fundus Angiography using a Nonadaptive Optics Imaging System

Dark-Adapted Two-Color Fundus-Controlled Perimetry in Macular Telangiectasia Type 2

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Longitudinal Assessment Of Reading Test Performance In Patients With Type 2 Macular Telangiectasia (MacTel)

Twelve-month longitudinal study of remnant cone structure in macular telangiectasia type 2

Macular photoreceptor atrophy defines the end stage of macular telangiectasia type 2

Human Serum Metabolomics Study in Macular Telangiectasia Type 2

High-Performance Virtual Reality Volume Rendering of Original Optical Coherence Tomography Point-Cloud Data Enhanced With Real-Time Ray Casting

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring

Retinal Layer Location of Increased Retinal Thickness and Retinal Thinning on the cohort of the EUROCONDOR clinical trial

Imaging of remnant cone structure in outer retinal lesions in macular telangiectasia (MacTel) type 2

Clinical Features Predict Diabetic Retinopathy Progression

Changes in glycated hemoglobin levels following consultation with diabetes specialist nurse in retinal clinics

To View More...

You must be signed into an individual account to use this feature.